Melodiol Global Health (AU:ME1) has released an update.
Melodiol Global Health Limited has announced the issuance of new fully paid ordinary shares, in accordance with the Corporations Act, without requiring a disclosure document. The company confirms compliance with the relevant provisions of the Act and asserts that there is no undisclosed information that would be reasonably expected by investors. Melodiol specializes in high-quality cannabis and plant-based products aiming to improve the health of people and animals.
For further insights into AU:ME1 stock, check out TipRanks’ Stock Analysis page.
